Best Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.99 Cr
as on 06-07-2024
- Paid Up Capital ₹ 4.99 Cr
as on 06-07-2024
- Company Age 21 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -11.67%
(FY 2018)
- Profit -18.72%
(FY 2018)
- Ebitda 307.06%
(FY 2018)
- Net Worth -8.40%
(FY 2018)
- Total Assets 13.58%
(FY 2018)
About Best Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.99 Cr and a paid-up capital of Rs 4.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Saxena and Satinder Singh serve as directors at the Company.
- CIN/LLPIN
U74999DL2003PTC123593
- Company No.
123593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Best Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Saxena  | Director | 29-Mar-2018 | Current |
| Satinder Singh | Director | 01-Dec-2017 | Current |
Financial Performance and Corporate Structure Insights of Best Laboratories.
Best Laboratories Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 11.67% decrease. The company also saw a substantial fall in profitability, with a 18.72% decrease in profit. The company's net worth dipped by a decrease of 8.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Best Laboratories?
In 2018, Best Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rexcin Pharmaceuticals Private LimitedActive 21 years 4 daysPradeep Saxena and Satinder Singh are mutual person
Rexcin Healthcare Private LimitedActive 21 years 4 daysPradeep Saxena and Satinder Singh are mutual person
- Rexcin Drugs Private LimitedActive 21 years 4 days
Pradeep Saxena and Satinder Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Best Laboratories?
Best Laboratories has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Best Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Best Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
